Organic Halides

2,6-Dibromoanthracene is an aromatic hydrocarbon that can be synthesized in a cross-coupling reaction. It has been shown to have a high electron mobility and good thermal stability. The compound was prepared by the Suzuki coupling reaction of 2,6-dibromobenzene with phenylboronic acid. This product has no commercial use but has been tested for its transport properties and has been found to be activated by heat.

3,4-Difluorobenzyl amine (3,4-DFBA) is a synthetic compound that has been shown to have anti-cancer properties. It has been used in the synthesis of perovskites as an alternative strategy for solar cell applications. 3,4-DFBA has also been used to investigate the effect of hydrophobic and deformation on the biological activity of amines. This compound inhibits aldehyde oxidase and catalase from glyoxal and hydrogen peroxide respectively, which may be due to its ability to form microcapsules with a diameter of less than 50 nm.

Please enquire for more information about 6-Bromo-3-(4-chlorophenyl)quinazoline-2,4(1H,3H)-dione including the price, delivery time and more detailed product information at the technical inquiry form on this page

Fluorinated benzopyran.  Nebivolol precursor.

5-Bromo-1H-indole-2-carboxylic acid methyl ester is a drug that belongs to the class of carboxylates. It has been shown to inhibit the growth of tumor cells in vitro and in vivo. The antitumor activity of this compound may be due to its ability to stabilize planar indole moieties, which are cytotoxic. 5-Bromo-1H-indole-2-carboxylic acid methyl ester interacts with other molecules through intermolecular interactions and can form an indole ring system that has a trifluoromethyl group and a carboxylate group in its structure.

Diisopropylammonium dichloroacetate (DADCA) is a chemical that inhibits the metabolism of glucose. It has been shown to have a hypoglycemic effect in rats and is being investigated as a treatment for metabolic disorders such as diabetes and obesity. DADCA has also been shown to reduce liver lesions in animals with chronic viral hepatitis, and has been found to be effective in reducing tumor growth in mice. This drug can also be used to treat bowel disease by reducing the amount of ammonia released by bacteria. DADCA may also have physiological effects on humans, including an increase in blood pressure and fever, although these effects have not yet been studied.

WAY 316606 is a potent, orally administered small molecule that inhibits the Wnt signaling pathway by blocking the action of β-catenin. It has been shown to have potential for treating eye disorders, including age-related macular degeneration. This drug also has potential for treatment of cell and nervous system diseases such as Alzheimer's disease and Huntington's disease. WAY 316606 inhibits the transcriptional activity of the β-catenin/Tcf4 complex by binding to it and preventing its translocation into the nucleus. In addition, WAY 316606 prevents downstream activation of genes regulated by β-catenin signaling, including c-myc and cyclin D1. This drug also blocks growth factor receptor tyrosine kinases and monoclonal antibodies that activate these receptors.

L-Tryptophanamide hydrochloride is a fluorescent compound that belongs to the amides. It has been shown to have invertase activity and be hydrated in both isooctane and water. L-Tryptophanamide hydrochloride also has an anxiolytic effect on mice, which may be due to its ability to inhibit the production of serotonin at synapses by blocking the enzyme tryptophan hydroxylase. The drug is used for the treatment of anxiety disorders, including generalized anxiety disorder (GAD) and posttraumatic stress disorder (PTSD). This drug has a molecular profile that can be detected by fluorescence spectrometry, with an enhancement factor of 1.5-2.5.